Fixed Price IPO | ₹7 Cr | Listed at BSE SME | Fri, Jun 21, 2019 - Wed, Jun 26, 2019
Earum Pharmaceuticals IPO is a fixed price issue of ₹6.65 crores. The issue is entirely a fresh issue of 0.18 crore shares of ₹6.65 crore.
Earum Pharmaceuticals IPO bidding started from Jun 21, 2019 and ended on Jun 26, 2019. The allotment for Earum Pharmaceuticals IPO was finalized on Jul 1, 2019. The shares got listed on BSE SME on Jul 4, 2019.
Earum Pharmaceuticals IPO price is ₹36 per share. The lot size for an application is 3,000. The minimum amount of investment required by an individual investor (retail) is ₹1,08,000 (3000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (6,000 shares), amounting to ₹2,16,000.
Hem Securities Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Hem Securities Ltd..
Refer to Earum Pharmaceuticals IPO RHP for detailed Information.
IPO Open
Fri, Jun 21, 2019
IPO Close
Wed, Jun 26, 2019
Issue Price
₹36 per share
Market Cap (Pre-IPO)
₹22.20 Cr
| IPO Date | 21 to 26 Jun, 2019 |
| Listed on | Thu, Jul 4, 2019 |
| Face Value | ₹10 per share |
| Issue Price | ₹36 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 18,48,000 shares (agg. up to ₹7 Cr) |
| Reserved for Market Maker | 96,000 shares Hem Securities Ltd. (agg. up to ₹0.3456 Cr) |
| Fresh Issue (Ex Market Maker) | 17,52,000 shares (agg. up to ₹6 Cr) |
| Net Offered to Public | 17,52,000 shares (agg. up to ₹6 Cr) |
| Share Holding Pre Issue | 43,19,910 shares |
| Share Holding Post Issue | 61,67,910 shares |
| BSE Script Code | 542724 |
| ISIN | INE060601015 |
Earum Pharmaceuticals IPO comprises a total issue size of 18,48,000 shares. The net offer to the public is 17,52,000 shares, after excluding 96,000 shares allotted on a firm basis. Of the Net offer 8,76,000 (50.00%) allocated to NII 8,76,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 8,76,000 | 50.00% | 47.40% |
| Retail Shares Offered | 8,76,000 | 50.00% | 47.40% |
| Firm Reservations | |||
| Market Maker Shares Offered | 96,000 | 5.19% | |
| Total Shares Offered | 18,48,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 3,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹1,08,000 |
| Retail (Max) | 1 | 3,000 | ₹1,08,000 |
| HNI (Min) | 2 | 6,000 | ₹2,16,000 |
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in trading, marketing, distribution of pharmaceutical formulation products. The company has 125 drugs formulation products including multivitamins, gynaecology drugs, steroids, anti-biotic drugs, cerebral activator drugs, gastrointestinal drugs, etc.
The company is also involved in the trading business of active pharmaceutical ingredients (API's) including Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP and Albendazole IP. Earum Pharmaceuticals is primarily engaged in two types of business activities; marketing of its own formulations products and trading of other brands' generic formulations. Currently, it has around 24 products which are manufactured by 3rd parties and marketed by the company under its brand name.
It has a warehouse at Ahmedabad, Gujarat equipped with all amenities to process business operations smoothly. The company has a domestic and international presence across South East Asia, Latin America and Africa.
Future goals of Earum Pharmaceuticals Ltd are:
1. Make global presence more prominent
2. Enhance customer satisfaction by improving market skills
3. Deal in quality standard products
The competitive strengths of the company are:
1. Wide product range
2. The experienced promoter of 11+ years experience
3. Quality assurance
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Working Capital requirement | 5.00 |
| 2 | General Corporate Purpose | 0.86 |
| 3 | To meet Issue Expenses | 0.79 |
The Earum IPO is subscribed 1.6 times on June 26, 2019 6:50:02 PM (Day 4). The public issue subscribed 1.48 times in the retail category, [.] times in the QIB category, and 1.72 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 1.72 | 8,76,000 | 15,03,000 |
| Retail | 1.48 | 8,76,000 | 12,99,000 |
| Total | 1.6 | 17,52,000 | 28,02,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manger Fees | 0.25 |
| 2 | Underwriting Commission and Processing Fees | 0.31 |
| 3 | Fees Payable to Registrar to the Issue | 0.01 |
| 4 | Fees Payable to Advertising and Marketing Expenses | 0.03 |
| 5 | Fees Payable to Regulators including Stock Exchanges | 0.04 |
| 6 | Payment for Printing & Stationery, Distribution, Postage, etc | 0.03 |
| 7 | Others ( Marketing and Selling Fees, Fees to Legal Advisors, Fees Payable to Statutory Auditor and Miscellaneous Expenses) | 0.12 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹36.00 |
| Open | ₹36.00 |
| Low | ₹36.00 |
| High | ₹36.15 |
| Last Trade | ₹36.05 |
Lead Manager Reports
Earum Pharmaceuticals IPO is a SME IPO of 18,48,000 equity shares of the face value of ₹10 aggregating up to ₹7 Crores. The issue is priced at ₹36 per share. The minimum order quantity is 3000.
The IPO opens on Fri, Jun 21, 2019, and closes on Wed, Jun 26, 2019.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Earum Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Earum Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Earum Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Earum Pharmaceuticals IPO opens on Fri, Jun 21, 2019 and closes on Wed, Jun 26, 2019.
Earum Pharmaceuticals IPO lot size is 3000, and the minimum amount required for application is ₹1,08,000.
You can apply in Earum Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Earum Pharmaceuticals IPO will be done on Monday, July 1, 2019, and the allotted shares will be credited to your demat account by Wed, Jul 3, 2019. Check the Earum Pharmaceuticals IPO allotment status.
The Earum Pharmaceuticals IPO listing date is on Thu, Jul 4, 2019.
